US CDC recommends Bavarian Nordic’s Jynneos vaccine for routine use in adults
The ACIP panel voted to recommend that 18 years and older individuals with certain risk factors should be…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Oct 23
The ACIP panel voted to recommend that 18 years and older individuals with certain risk factors should be…
25 Oct 23
The approval was based on the data from the Phase 1, multicentre study of IDH1-mutated R/R MDS patients…
25 Oct 23
OncoCare is a medical oncology clinic group with seven clinics at hospitals and medical centres whereas NHC is…
25 Oct 23
The governing body has launched a European Voluntary Solidarity Mechanism, will create a union list of critical medicines,…
24 Oct 23
The enlarged company after the subsequent merger is anticipated to operate under the name NAYA Biosciences and will…
24 Oct 23
The approval is supported by the safety and efficacy data from the Phase 3 HERO trial of Orgovyx…
24 Oct 23
Certa previously announced positive top-line results from a Phase 2 study which indicated that treatment with FT011 for…
20 Oct 23
Within the framework of the collaboration, Mayo Clinic and Oxford Nanopore have identified several key areas of development,…
20 Oct 23
Aspen plans to initiate a first-in-patient Phase 1/2a clinical trial of ANPD001 for participants with moderate to severe…
19 Oct 23
Nuvaxovid is a protein-based ready-to-use vaccine developed by creating copies of the surface spike protein of SARS-CoV-2, a…